Status:
UNKNOWN
Paraneoplastic Neurologic Encephalitis and Mature Cystic Teratoma
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
Ovarian Dermoid Cyst
Eligibility:
FEMALE
20-50 years
Brief Summary
Ovarian dermoid cyst, also known as benign mature teratoma, originate from germ cells in the ovary, and is the most common benign ovarian tumor (44-70%). Several reports documented a secretion of NMDA...
Detailed Description
The data is collected by examining women's serum for the presence of NMDA-R antibodies, using special ELISA (enzyme-linked immunoabsorbent assay) kits. The analysis will be made by Dyn diagnostics lab...
Eligibility Criteria
Inclusion
- Women admitted for surgery for removal of suspected dermoid cysts
- No neurologic symptoms
Exclusion
- No surgical specimen available
- The cyst pathology does not show dermoid cyst characteristics
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05223543
Start Date
January 1 2020
End Date
October 30 2022
Last Update
February 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shamir medical center
Rishon LeZiyyon, Israel, Zrifin